Pharmacological treatment of mechanical edema: A randomized controlled trial about the effects of mesoglycan

European Journal of Physical and Rehabilitation Medicine

Volumn 45, Issue 1, 2009, Pages 21-29

  Viliani, T ^a   Scarselli, M ^a   Pieri, A ^a   Gatti, M ^a   Santini, M ^a   Pasquetti, P ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Capillary permeability; Edema; Hypertension; Mesoglycan

Indexed keywords

GLYCOSAMINOGLYCAN; MESOGLYCAN;

ADULT; AGED; ARTICLE; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDEMA; FEMALE; HUMAN; LEG; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VASCULARIZATION; VEIN INSUFFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; EDEMA; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; LEG; MALE; MIDDLE AGED; PHYSICAL THERAPY MODALITIES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 67650482351     PISSN: 19739087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Mariani F. Edema of the lower limb: differential diagnosis and therapy. Int J Practice Cardiol 2004;2:61-69
2. Szczesny G, Olszewsky WL. The pathomechanism of post-traumatic edema of lower limbs: I. The effect of extravasated blood, bone marrow cells, and bacterial colonization on tissues, lymphatics, and lymph nodes. J Trauma 2002;52:315-322
3. Szczesny G, Olszewsky WL. The pathomechanism of posttraumatic edema of lower limbs: II. Changes in the lymphatic system. J Trauma 2003;55:350-354 (Pubitemid 37047408)
4. TerryM,O'BrienSP,KersteinMD.Lower-extremityedema:evaluationanddiagnosis. Wounds1998;10:118-124(Pubitemid128120613)
5. Orsted HL, Radke L, Gorst R. The impact of musculoskeletal changes on the dynamics of the calf muscle pump. Ostomy/Wound management 2001;47:18-24.
6. Merli GJ, Spandoper J. The outpatients with unilateral leg swelling. Med Clin North Am 1995;2:435-447
7. Young JR. The swollen leg: clinical significance and differential diagnosis. Cardiol Clin 1991;9:443-456
8. Padberg FT, Johnston MV, Sisto SA. Structured exercise improves calf muscle pump function in chronic venous insufficiency: a randomised trial. J Vase Surg 2004;39:79-87. (Pubitemid 38056156)
9. Liu R, Lao TT, Kwok YL, Li Y, Ying MT. Effects of graduated compression stockings with different pressure profiles on lowerlimb venous structures and haemodynamics. Adv Ther 2008; 25:465-78.
10. Ibegbuna V, Delis IC, Nicolaides AN. Effect of lightweight compression stockings on venous haemodynamics. Int Angiol 1997;16:185-188
11. SitziaJ.Areviewofoutcomeindicatorsinthetreatmentofchroniclimbedema. ClinRehabil1997;3:181-191(Pubitemid27458523)
12. ElyGV,OsheroffJA,ChamblissML,EbellMH.Approachtolegedemaofunclearetiology. JAmBoardFamMed2006;19:148-160(Pubitemid44046977)
13. Morris RJ, Woodcock JP. Evidence-based compression. Prevention of stasis and deep vein thrombosis. Ann Surg 2004;239:162-171
14. PerrinM,GeroulakosG.Pharmacologicaltreatmentofchronicvenousdisorders. Phlebolymphology2007;4:23-30.(Pubitemid46050471)
15. Tiwari A, Cheng KS, Button M, Myint F1 Hamilton G. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg 2003;138:152-161
16. Segre G. Aspetti farmacologici dei glicosaminoglicani. Minerva Med 1986;77:1859-1864
17. Caimi G, Romandini S, Lo Presti R, Serra A, Montana M, Francavilla G et al. Effect of mesoglycan on macrorheologic and microrheologic parameters. Curr Ther Res Clin Exp 1992;52:412-418
18. VittoriaA,MessaGL,FrigerioC,CelascoG,AuteriA. Effectofasingledoseofmesoglycanonthehumanfibrinolyticsystem, andtheprofibrinolyticactionofninedailydoses.IntJTissueReact1988;4: 261-266(Pubitemid19101384)
19. ZanoloG,GiachetiC.Pharmacokineticaspectoftritium- labelledglycosaminoglycans(mesoglycan) theirabsorptioninratandmonkeyandtissuedistributioninrat.BollChimFarm1984;123: 223-235(Pubitemid14070522)
20. De Donato G, De Nicola P, Meucci E. Valutazione strumentale degli effetti del mesoglicano in pazienti arteriopatici (stadio II di Fontaine) in uno studio in doppio cieco verso placebo. Farmaci e Terapia 1991;8:84-88
21. NenciGG,GreseleP,FerrariG,SantoroL,GianeseF. Treatmentofintermittentclaudicationwithmesoglycan,aplacebo-controlled, double-blindstudy.ThrombHaemost2001;86:1181-1187(Pubitemid33064565)
22. Agrifoglio G, Di Perri T, Strano A. Studio multicentrico sull'efficacia e la tollerabilità del mesoglicano in pazienti affetti da malattia venosa. Farmaci 1989;13:107-115
23. Aluigi L, Rocchi P, Tamburini M, Accorsi F, Ridolfi C. Efficacia del mesoglicano nel trattamento dell'insufficienza venosa crónica. Giornale Italiano di Ricerche e Terapeutiche 1991;12:147-151
24. Andreozzi GM, Signorelli S, Martini R, Palazzo V, Garozzo G, Sciuto V et al. Effetti protettivi del mesoglicansolfato sulla trombogenesi venosa. Minerva Med 1986;77:1883-1886
25. Arosio E, Ferrari G, Santoro L, Gianese F, Coccheri S. A placebo- controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers. Eur J Vase Endovasc Surg 2001;22:365-372 (Pubitemid 32923116)
26. Andreozzi GM. Effectiveness of mesoglycan in patients with previous deep vein thrombosis and chronic venous insufficiency. Minerva Cardioangiol 2007;55:741-753
27. Borg G. Borg's perceived exertion and pain scales. 1st ed. Stockholm: Human Kinetics Publishers; 1998. p. 111-112
28. WeissJM,SprayBJ. Theeffectofcompletedecongestivetherapy onthequalityoflifeofpatientswithperipherallymphedema.Lymphology2002;35:46-58. (Pubitemid34627660)
29. Brotzman SB, WiIk KE. La riabilitazione in ortopedia. 2nd ed. Milano: Excerpta Medica; 2003. p. 371-390, 441-74, 357-62, 588-99, 412-6.
30. Guingand O, Breton G. Rieducazione e artroplastica di ginocchio Encyclopedia Med Chir. Paris: Elsevier sas; 2004.26:296-A-05, 9-12.
31. Darnauld A, Nizard R, Guillemain J-L. Rieducazione dell'anca operata. Encyclopedia Med Chir. Paris: Elsevier sas; 2005.26,293A-05,14-18.
32. Kumar V, Abbas AK, Fausto N. Pathologic basis of disease. 7th ed. Philadelphia: Elsevier Saunders; 2005. p. 31-34
33. Cho S, Atwood J. Peripheral edema. Am J Med 2002;113:580-586 (Pubitemid 35379914)
34. Filho WT, Piccinato CE, Moriya T, Joviliano EE, Dezotti NRA. Influence of shoe on heel height on venous function in young women. IX Panamerican Congress on Vascular and Endovascular Surgery. 2006 Oct 31-Nov 4; Rio de Janeiro, Brasil.
35. Lunzer MM, Hotvedt PS, Dietz CA, Caldwell MD, Serfass RC, Hirsch AT. Limb venous hemodynamic function: relative reproducibility of standard tip-toe exercise and treadmill walking exercise techniques. J Vase Technol 1997;21:31-38
36. ChristopoulosD,NicolaidesAN,CookA,IrvineA,GallowayJM,WilkinsonA. Pathogenesisofvenousulcerationinrelation-thecalfmusclepumSurgery1989;106: 829-835(Pubitemid19283375)
37. Back TL, Padberg FT, Araki CT, Thompson PN, Hobson RW. Limited range of motion is a significant factor in venous ulceration. J Vase Surg 1995;22:519-523
38. Colwell CV, Addams M, Murray J, Brady LP. Heparin and dihidroergotamine and antiedemigen drugs in the hip arthroplasty. J Bone Joint Surg 1998;67:534.
39. MaloneySchurmanDJ,HangenD. Theinfluenceofcontinuouspassivemotiononoutcomeintotalkneearthroplasty. ClinOrthop1990;256:162-168(Pubitemid20230470)
40. Struckmann JR. Clinical efficacy of micronized purified flavonoid fraction: an overview. J Vase Res 1999;36(Suppl l):37-4l. (Pubitemid 29411273)